Motley Fool Asset Management »

Iovance Biotherapeutics shares owned by Motley Fool Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Motley Fool Asset Management from 13F filings

Historical chart of Motley Fool Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Motley Fool Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $29k 11k 2.73

More positions owned by Motley Fool Asset Management

NVIDIA Corp. Ordinary Shares (NVDA)
Alphabet Ordinary Shares (GOOG)
Apple Ordinary Shares (AAPL)
Microsoft Corp. Ordinary Shares (MSFT)
Amazon.com Ordinary Shares (AMZN)
Meta Platforms Ordinary Shares (META)
Broadcom Ordinary Shares (AVGO)
MasterCard Incorporated Ordinary Shares (MA)
Visa Ordinary Shares (V)
Tesla Ordinary Shares (TSLA)
Costco Wholesale Corporation Ordinary Shares (COST)
Walmart Ordinary Shares (WMT)
Netflix Ordinary Shares (NFLX)
Berkshire Hathaway Ordinary Shares (BRK.B)
JPMorgan Chase & Co. Ordinary Shares (JPM)

View all positions for Motley Fool Asset Management

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Invenomic Capital Management
Goldman Sachs Group
Long Focus Capital Management
Geode Capital Management
Palo Alto Investors
Susquehanna International
Citadel Advisors
Millennium Management
Hrt Financial
Jane Street
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics